Clinical Trials for Allergies and Immunologic Disorders
We at the Division of Allergy and Immunology at Cincinnati Children’s are devoted to providing the best care for our patients. Our dedicated clinical staff partner with families to improve the health and quality of life of our patients. Our involvement in human research studies, also known as clinical trials, helps us to determine what treatments and strategies work best for our patients. Our division’s clinical trials team is dedicated to bringing cutting-edge therapies to our child and adult patients.
For more about our clinical trials, visit these clinicaltrials.gov webpages:
- Allergic Disease Onset Prevention Study (ADORED)
- Long-term Extension Study of Ligelizumab in Food Allergy
- Infant Formula in Infants and Children With Cow's Milk Allergy
- Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of Age
- Observational Evaluation of Atopic Dermatitis in Pediatric Patients (PEDISTAD)
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
- Zemaira Eosinophilic Esophagitis Pilot Study (ZEEPS)
- Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis (CROSSING)
- A Study of CDX-0159 in Patients With Eosinophilic Esophagitis (EvolvE)
- Dupilumab in Eosinophilic Gastritis (DEGAS)
- A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis (ENGAGE)
- Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
- Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial (DESTINY)